Ultragenyx Reports Second Quarter 2022 Financial Results and Corporate Update
Go back to Ultragenyx Reports Second Quarter 2022 Financial Results and Corporate Update| ULTRAGENYX PHARM (NASDAQ: RARE) | Delayed: 14.64 +0.14 (0.97%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $14.50 | 52 Week High | $117.12 | |||
| Open | $14.79 | 52 Week Low | $46.52 | |||
| Day High | $15.04 | P/E | N/A | |||
| Day Low | $14.07 | EPS | $-1.97 | |||
| Volume | 5,910,630 | |||||
